Literature DB >> 18395151

Fertility and sexuality in young cancer survivors who have adult-onset malignancies.

Sophie D Fosså1, Alv A Dahl.   

Abstract

Post-treatment fertility and sexuality are important issues to be considered before treatment starts in young adult patients who have cancer. Most male cancer survivors who have malignancies typical for young adulthood preserve the potential to father a child. Fertility remains decreased in comparable females treated for cancer in reproductive years. Postdiagnosis sexual life is affected, more so in females than in males, and was found to be strongly associated with emotional aspects of partnership. Communication about fertility and sexuality must become an integrated part of cancer survivors' follow-up.

Entities:  

Mesh:

Year:  2008        PMID: 18395151     DOI: 10.1016/j.hoc.2008.01.002

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  4 in total

1.  Medical and psychosocial aspects of fertility after cancer.

Authors:  Christine Duffy; Susan Allen
Journal:  Cancer J       Date:  2009 Jan-Feb       Impact factor: 3.360

2.  Does varicocelectomy improve gonadal function in men with hypogonadism and infertility? Analysis of a prospective study.

Authors:  Vasan Sathya Srini; Srinivas Belur Veerachari
Journal:  Int J Endocrinol       Date:  2011-11-29       Impact factor: 3.257

3.  Sexuality and cancer in adolescents and young adults - a comparison between reproductive cancer patients and patients with non-reproductive cancer.

Authors:  Julian Mütsch; Michael Friedrich; Katja Leuteritz; Annekathrin Sender; Kristina Geue; Anja Hilbert; Yve Stöbel-Richter
Journal:  BMC Cancer       Date:  2019-08-22       Impact factor: 4.430

Review 4.  Sexual health-related care needs among young adult cancer patients and survivors: a systematic literature review.

Authors:  Vicky Lehmann; Ellen T M Laan; Brenda L den Oudsten
Journal:  J Cancer Surviv       Date:  2021-10-20       Impact factor: 4.062

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.